Top image

EMBL Conference

Cancer Genomics

EMBL Heidelberg, Germany Sunday 3 November - Tuesday 5 November 2013 Registration closed
Abstract submission closed

Download Poster

Conference Programme

The 2013 programme

Day 1 - Sunday 3 November
11:00-13:00 Arrival and Registration (light lunch will be available)
13:00-13:15 Welcome 
13:15-18:45 Session I: Cancer Genetics
Chairs: Ido Amit & Valerie LeBleu
13:15-14:15 Keynote Lecture: Taking Insights from CLL Genomic Sequencing to the Clinics
Elias Campo, Hospital Clinic, University of Barcelona
Chair: Lynda Chin
14:15-14:45 Translating Cancer Genomics kindly sponsored by illumina
Elaine Mardis, The Genome Institute at Washington University
14:45-15:15 Coffee break 
15:15-15:30 Selected talk: Peter Van Loo
15:30-16:00 Lynda Chin, MD Anderson Cancer Center 
16:00-16:15 Selected talk: Giorgio Melloni
16:15-16:45 Genomics of Germinal Center derived B-Cell Lymphomas  
Reiner Siebert, Kiel University
16:45-17:15 Coffee break 
17:15-17:45 Cancer Genomics to aid in clinical decision making 
Steven Jones, BC Cancer Agency
17:45-18:00 Selected talk: Anders Isaksson
18:00-18:15 Selected talk: Jorge Zeron-Medina
18:15-18:45 Discovery and characterization of cancer susceptibility alleles:
Towards an understanding of how the germ line informs somatic alterations of cancer

Stephen Chanock, National Cancer Institute 
18:45-20:00 Dinner 
20:00-21:00 Keynote Lecture: Genetic predisposition to cancer – new horizons  
Nazneen Rahman, The Institute of Cancer Research
Chair: Jan Korbel
21:00-22:30 Welcome reception & Poster preview session (Roof Top Lounge will be open)
Day 2 - Monday 4 November
09:00-12:30 Session 2: Functional Genomics & Epigenomics of Cancer
Chairs: Nazneen Rahman & Elias Campo
09:00-09:30 Principles of Chromatin and Gene expression dynamics  
Ido Amit, Weizman Institute of Science
09:30-09:45 Selected talk: Eva Berglund
09:45-10:15 Peter Lichter, German Cancer Research Center 
10:15-10:30 Selected talk: Alessandro Romanel
10:30-11:00 Coffee break 
11:00-11:30 Multi-Level Long-Rang and Spatial Regulation of Gene Transcription in Cancer Cells
Yijun Ruan, The Jackson Laboratory, University of Connecticut Medical School
11:30-11:45 Selected talk: Michal P. Switnicki
11:45-12:15 Challenges of Sequence Data Analysis
Ivo Gut, Centro Nacional de Análisis Genómico 
12:15-12:30 Selected talk: Stein Aerts
12:30-14:00 Lunch 
14:00-18:30 Session 3: Systems Biology & Integrated Analysis of Cancer
Chairs: Elaine Mardis & Steve Jones
14:00-14:30 Circular RNAs
Nikolaus Rajewsky, MDC Berlin
14:30-14:45 Selected talk: Marco J. Morelli
14:45-15:00 Selected talk: Arend Sidow
15:00-15:30 Integrated Approach to Determining the Functional Role of Tumor Stroma in Pancreatic Cancer
Valerie LeBleu, Harvard Medical School 
15:30-15:45 Selected talk: Moritz Gerstung
15:45-16:30 Coffee break & Meet the Speakers

Analysis of cancer changes in the non coding genome
Ewan Birney, EMBL-EBI 


Selected talk: Ekta Khurana

17:15-17:45 The Cancer Genome Atlas Pan-Cancer Analysis Project
Josh Stuart, Universtiy of California, Santa Cruz
17:45-18:00 Mapping cancer specific drug-gene interactions
Wolfgang Huber, EMBL Heidelberg
18:00-18:30 Somatic DNA alterations in the cancer genome
Jan Korbel, EMBL Heidelberg 
18:30-19:45 Poster session I (#45 - 83 on Helix A)
19:45-00:00 Conference Dinner and Party 
Day 3 - Tuesday 5 November
09:00-12:30 Session IV: Cancer Model Systems & Systems Pharmacology
Chairs: Peter Lichter & Stephen Chanock
09:00-09:30 Deciphering drug response in the era of cancer genomes
Ultan McDermott, Wellcome Trust Sanger Institute 
09:30-09:45 Selected talk: Madara Ratnadiwakara

The cancerous protein translation program
Yitzhak Pilpel, Weizman Institute of Science 

10:15-10:30 Selected talk: Florence Cavalli
10:30-11:00 Coffee break 
11:00-11:30 Sequence analysis of mouse and human lung adenocarcinomas
Katerina Politi, Yale University 
11:30-11:45 Selected talk: Gerald Goh
11:45-12:00 Selected talk: Shameem Fawdar

Molecular Stratification Identifies Exceptional Responders to Therapy for Pancreatic Cancer
Andrew V. Biankin, Wolfson Wohl Cancer Research Centre, University of Glasgow 

12:30-13:30 Lunch 
13:30-14:45 Poster session II (#84 - 121 on Helix A)
14:45-19:15 Session V: Translation and Clinical Impact of Cancer Genomics
Chairs: Ewan Birney & Andy Futreal
14:45-15:15 Peter Campbell, Wellcome Trust Sanger Institute 
15:15-15:30 Selected talk: Jelena Belic
15:30-15:45 Selected talk: John Castle
15:45-16:15 Genomic of benign and malignant liver tumors
Jessica Zucman-Rossi, Inserm U674
16:15-17:00 Coffee break & Meet the Speakers
17:00-17:30 Decoding clonal evolution in human cancers
Sam Aparicio, BC Cancer Agency 

A systems biology approach to elucidate mechanisms of tumor initiation, progression,
and chemosensitivity
Andrea Califano, Columbia University

18:00-19:00 Keynote lecture:
Andy Futreal, MD Anderson Cancer Center
Chair: Peter Campbell
19:00-19:15 Closing remarks